Search -

Displaying 621 - 640 of 1177

Sort: Relevancy | Date

News Daily News

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

Todd Neale

July 11, 2018

News Daily News

High CVD Risk in India Varies by State, Demographics

Todd Neale

June 20, 2018

News Conference News EuroPCR 2018

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Todd Neale

May 18, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Daily News

Ceiling-Suspended Shields Decrease Radiation Risk for TEE Operators During Structural Heart Procedures

Yael L. Maxwell

March 21, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

Caitlin E. Cox

March 11, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Advertisement

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

High CVD Risk in India Varies by State, Demographics

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Pace Quickens for Mitral Device Innovation for Repair, Replacement

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

TCTMD’s Top 10 Most Popular Stories for March 2018

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Ceiling-Suspended Shields Decrease Radiation Risk for TEE Operators During Structural Heart Procedures

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content